Search Results
Nov 20, 2025, 12:50 ET Lanchi Ventures Backed Genspark Raises $275M Series B, Launches AI Workspace to Put Busywork on Autopilot
technologies at Google in 2011, launching the world's first deep neural network ranking model in production search in 2013. Co-founder and COO Wen Sang holds a PhD from MIT and previously founded and exited Smarking, a Y Combinator and Khosla Ventures backed enterprise SaaS company. This expertise in building large-scale
More news about: Lanchi Ventures
Nov 20, 2025, 11:33 ET VIPC Signs MOU with AstraZeneca, Eli Lilly, Merck to Develop the Virginia Center for Advanced Pharmaceutical Manufacturing to Train Workforce of the Future
and upward mobility our region needs, while strengthening the commercialization engine that drives Virginia's biotech future," said Nikki Hastings, PhD, Executive Director of CvilleBioHub. About VIPC
More news about: VIPC
Nov 20, 2025, 10:04 ET Cannformatics and Dr. Laszlo Mechtler Announce Intent to Launch Lab Service for Personalized Medical Cannabis in Migraine and Other Conditions
"This collaboration expands Cannformatics's work into migraine, joining our ongoing research in autism and Alzheimer's disease," said Itzhak Kurek, PhD, Co-Founder and CEO of Cannformatics. "Dr. Mechtler's leadership at DENT and his pioneering work in medical cannabis bring unparalleled clinical depth
More news about: Cannformatics
Nov 20, 2025, 09:55 ET Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Rachel Bailey, PhD – University of Texas Southwestern Medical Center, Dallas, TX, USAGene Therapy to Cure an Ultra-Rare, Devastating Neurodevelopmental Metabolic Disorder of the SLC13A5 Citrate Transporter Esther Becker, PhD – University
More news about: Harrington Discovery Institute
Nov 20, 2025, 09:42 ET Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Rachel Bailey, PhD – University of Texas Southwestern Medical Center, Dallas, TX, USAGene Therapy to Cure an Ultra-Rare, Devastating Neurodevelopmental Metabolic Disorder of the SLC13A5 Citrate Transporter Esther Becker, PhD – University
More news about: Harrington Discovery Institute
Nov 20, 2025, 09:30 ET 6 Stages of Love Assessment by Thais Gibson and The Personal Development School Launches Online
The Personal Development School (PDS) was created to change that. Founded by attachment theory expert Thais Gibson, PhD, PDS offers a more accessible and efficient path to emotional and relational healing. Through affordable, science-based online programs available 24/7,
More news about: The Personal Development School
Nov 20, 2025, 09:05 ET UNREINED WHISKEY LAUNCHES AS OFFICIAL WHISKEY OF TEXAS A&M ATHLETICS
approach to whiskey is one that blends innovation, quality, and decades of experience to create a whiskey Texans are proud to share," said Rob Arnold, PhD, Co-Founder and board member of Unreined Whiskey. Unreined Whiskey's visitor center will open in College Station this spring with
More news about: Unreined Whiskey
Nov 20, 2025, 09:00 ET ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington's Disease Treatment and Announces Key Development Milestone
critical threshold (~150 CAG repeats), they cause neuronal death, leading to the development of HD symptoms. Paul R. August, PhD, Chief Scientific Officer at ReviR Therapeutics, commented on the grant's significance: "This CIRM grant is a cornerstone for our targeted approach in
More news about: ReviR Therapeutics
Nov 20, 2025, 09:00 ET The Power of Prevention: Detecting Diabetes Before It Strikes
Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian Ding, MD, PhD, Senior Medical Affairs Manager, QuidelOrtho, an expert in clinical and laboratory medicine with deep experience in healthcare information systems and
More news about: QuidelOrtho Corporation
Nov 20, 2025, 08:04 ET BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence
within the company's newly expanded Bothell headquarters, the Center is named in honor of one of BioLife Solutions' founding team members, Aby J. Mathew, PhD, who serves as the company's Executive Vice President and Chief Scientific Officer.
More news about: BioLife Solutions, Inc.
Nov 20, 2025, 08:00 ET ALS Network and ALS United Announce New Research Grantees
Fattahi, PhD; Sarah Kishinevsky, PhD, University of California San Francisco, and EverTree Bio for Evaluation of Glioprotective Small Molecules for ALS therapy. Clotilde Lagier-Tourenne, MD, PhD; Liron Bar-Peled, PhD, Massachusetts
More news about: ALS Network
Nov 20, 2025, 07:07 ET HealthTrackRx Laboratory Director Jessica Moye Named an ASCP 2025 40 Under Forty Honoree
HealthTrackRx, HealthTrackRx proudly announces that Jessica Moye, PhD, MB(ASCP)CM, HCLD(ABB), Laboratory Director for our newest state-of-the-art lab location at UPS Healthcare Labport, has been recognized by the American
More news about: HealthTrackRx
Nov 20, 2025, 07:00 ET SciNeuro Pharmaceuticals to Accelerate Novel LRRK2 Therapeutic (SNP614) Development with an Award from The Michael J. Fox Foundation
funding will catalyze the ongoing development of SNP614 toward IND, positioning the program for clinical translation. Min Li, PhD, Founder and CEO of SciNeuro, said: "We are honored to receive this award by The Michael J. Fox Foundation, a leader in Parkinson's Disease research,
More news about: SciNeuro Pharmaceuticals
Nov 20, 2025, 05:03 ET LUNGevity Invests in Lung Cancer Workforce Expansion Through Four Strategic Research Awards
"It is imperative that we build a vibrant lung cancer workforce to meet the growing needs of the lung cancer community," said Upal Basu Roy, PhD, MPH, Executive Director of LUNGevity Research. "These awards support research in strategic areas of need and they have the potential to transform lung
More news about: LUNGevity Foundation
Nov 19, 2025, 15:30 ET With a $2.5B Valuation, Function Becomes the New Standard for Health and Launches Medical Intelligence Lab
company unveils its Medical IntelligenceLab (MI Lab). The MI Lab, co-directed by Function's Chief Medical Scientist, Dan Sodickson M.D., PhD, brings together a team of top clinicians, researchers and technologists. AI alone is not enough to understand and manage one's health. The MI Lab focuses
More news about: Function Health
Nov 19, 2025, 14:17 ET A New Approach to Understanding Nutrient Intake: An ILSI US & Canada Framework
current system of food labeling, which reports total nutrient content without considering bioavailability, has limitations," said Connie Weaver, PhD, Distinguished Professor at San Diego State University and chair of the ILSI expert committee. "This new framework addresses these gaps by adjusting
More news about: International Life Sciences Institute
Nov 19, 2025, 14:04 ET The Center for Cancer and Blood Disorders and Adjuvant Behavioral Health Partner to Bring Whole-Person Cancer Care to North Texas
Dr. Josh Myers, PhD, LPC-S, and CEO at Adjuvant Behavioral Health. "We are honored to work alongside CCBD to care for patients not just physically, but emotionally and mentally,
More news about: Adjuvant Behavioral Health
Nov 19, 2025, 11:02 ET Men Lead Spending on "Little Luxuries" amid Growing Economic Caution
mix of mindful indulgence and broader consumer trends—healthier eating, shared experiences, and affordable entertainment," said Denise Dahlhoff, PhD, Director of Marketing & Communications Research at The Conference Board and author of the report. "Consumers value affordable, feel-good everyday
More news about: The Conference Board
Nov 19, 2025, 10:20 ET Amy Rudolph, PhD, Joins Thryv Therapeutics' Board of Directors to Support Portfolio Progression into Heart Failure
(SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic diseases, and cardiomyopathies, today announced the appointment of Amy Rudolph, PhD, to its Board of Directors. Dr. Rudolph brings more than 25 years of leadership experience in the global pharmaceutical industry, with deep expertise
More news about: Thryv Therapeutics Inc.
Nov 19, 2025, 10:13 ET Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
modality-associated challenges and poor translation in preclinical models, underscoring the need for a more precise RNA-targeting approach," said Martin Jacko, PhD, Founder and CEO of Aperture Therapeutics. "By directly modulating CD33 at the RNA level, APRTX-001 overcomes these historical barriers with a precision
More news about: Aperture Therapeutics
Nov 19, 2025, 09:51 ET Alzheimer's Drug Discovery Foundation Launches Milestones in Motion Campaign and Announces Fifth Season of Symposium Series in Palm Beach
WEDNESDAY, NOVEMBER 19, 2025, 3:00 PM "Regenerating the Aging Brain," featuring Roberta Diaz Brinton, PhD Dr. Roberta Diaz Brinton, Inaugural Director of the Center for Innovation in Brain Science at University of Arizona Health
More news about: Alzheimer's Drug Discovery Foundation
Nov 19, 2025, 09:37 ET Visage Propels AI Optimized Enterprise Imaging at RSNA 2025
Pro is helping to pioneer what's possible in radiology. Join Elias Kikano, MD, Paul Murphy, MD, and Andrew Gordon, MD, along with Malte Westerhoff, PhD, as they share insights on how spatial computing is transforming medical imaging. They'll also discuss personal experiences within their own healthcare
More news about: Visage Imaging, Inc.
Nov 19, 2025, 09:00 ET alphaXiv Raises $7M Seed Round to Bridge the AI Research-to-Practice Divide
larger audience for research than today," said Sebastian Thrun. "People are looking for new ways to get involved in research that go beyond having a PhD. A decade ago everyone wanted to be a software engineer. Today they want to be a research engineer." Beyond industry, alphaXiv
More news about: alphaXiv
Nov 19, 2025, 08:48 ET Ventoux Biosciences Launches Research Program Targeting Spinal Cord Injury with VEN-201
lead compound, VEN-201, in translational preclinical models of spinal cord injury (SCI). The research will be conducted by Dr. Michael Sofroniew, MD, PhD, Distinguished Professor of Neurobiology at the David Geffen School of Medicine at UCLA and a global leader in central nervous system (CNS) injury and
More news about: Ventoux Biosciences
Nov 19, 2025, 08:15 ET ExeGi Pharma Launches Visbiome Vet GI Care+ in Canada
(NN.O0R3). "Pets rely on a healthy, balanced gut microbiome for normal digestion and immune function," said Dr. Caroline Mansfield, PhD, DACVM at Michigan State College of Veterinary Medicine. "Visbiome Vet GI Care+ has some impressive clinical data which helps to support it as an emerging
More news about: ExeGi Pharma